Table of Content


Introduction
Non Receptor Tyrosine Protein Kise TYK2 (TYK2 or EC 2.7.10.2) - Overview
Non Receptor Tyrosine Protein Kise TYK2 (TYK2 or EC 2.7.10.2) - Therapeutics Development
Non Receptor Tyrosine Protein Kise TYK2 (TYK2 or EC 2.7.10.2) - Therapeutics Assessment
Non Receptor Tyrosine Protein Kise TYK2 (TYK2 or EC 2.7.10.2) - Companies Involved in Therapeutics Development
Non Receptor Tyrosine Protein Kise TYK2 (TYK2 or EC 2.7.10.2) - Drug Profiles
Non Receptor Tyrosine Protein Kise TYK2 (TYK2 or EC 2.7.10.2) - Dormant Products
Non Receptor Tyrosine Protein Kise TYK2 (TYK2 or EC 2.7.10.2) - Discontinued Products
Non Receptor Tyrosine Protein Kise TYK2 (TYK2 or EC 2.7.10.2) - Product Development Milestones
Appendix



List of Figures

List of Figures
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Top 10 Indications, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Stage and Molecule Type, 2021

List of Tables

List of Tables
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indications, 2021
Number of Products under Development by Indications, 2021 (Contd..1)
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Companies, 2021 (Contd..4)
Products under Development by Companies, 2021 (Contd..5)
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by AbbVie Inc, 2021
Pipeline by Alexion Pharmaceuticals Inc, 2021
Pipeline by Amgen Inc, 2021
Pipeline by Atomwise Inc, 2021
Pipeline by Bristol-Myers Squibb Co, 2021
Pipeline by Esker Therapeutics Inc, 2021
Pipeline by Galapagos NV, 2021
Pipeline by Haisco Pharmaceutical Group Co Ltd, 2021
Pipeline by InnoCare Pharma Ltd, 2021
Pipeline by Merck & Co Inc, 2021
Pipeline by Neuron23 Inc, 2021
Pipeline by Nimbus Therapeutics LLC, 2021
Pipeline by Oncostellae SL, 2021
Pipeline by Pfizer Inc, 2021
Pipeline by Sareum Holdings Plc, 2021
Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2021
Pipeline by Simcere Pharmaceutical Group Ltd, 2021
Pipeline by Technoderma Medicines Inc, 2021
Pipeline by Theravance Biopharma Inc, 2021
Pipeline by TLL Pharmaceutical LLC, 2021
Pipeline by Ventyx Biosciences Inc, 2021
Dormant Products, 2021
Dormant Products, 2021 (Contd..1)
Discontinued Products, 2021